blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2879690

EP2879690 - TARGETED OESOPHAGEAL ADMINISTRATION OF ZN-ALPHA2-GLYCOPROTEINS (ZAG), METHODS AND FORMULATIONS THEREOF [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  14.06.2019
Database last updated on 05.10.2024
FormerExamination is in progress
Status updated on  18.11.2016
Most recent event   Tooltip14.06.2019Application deemed to be withdrawnpublished on 17.07.2019  [2019/29]
Applicant(s)For all designated states
Aston University
Aston Triangle
Birmingham B4 7ET / GB
[2015/24]
Inventor(s)01 / TISDALE, Michael
Wellcot
Star Lane
Claverdon Warwickshire CV35 8LW / GB
02 / RUSSELL, Steven
18 Victory Road
Wedensbury West Midlands WS10 7RR / GB
 [2015/24]
Representative(s)Cornish, Kristina Victoria Joy, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[N/P]
Former [2015/24]Ruiz Antoli, Soledad Cecilia, et al
Kilburn & Strode LLP
20 Red Lion Street
London WC1R 4PJ / GB
Application number, filing date13747684.231.07.2013
WO2013GB52039
Priority number, dateUS201261677984P31.07.2012         Original published format: US 201261677984 P
[2015/24]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014020333
Date:06.02.2014
Language:EN
[2014/06]
Type: A1 Application with search report 
No.:EP2879690
Date:10.06.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 06.02.2014 takes the place of the publication of the European patent application.
[2015/24]
Search report(s)International search report - published on:EP06.02.2014
ClassificationIPC:A61K38/17
[2015/24]
CPC:
A61K38/1741 (EP,US); A61K31/138 (EP,US); A61K38/1709 (EP,US);
A61K45/06 (US); A61K47/56 (EP,US); A61K9/0053 (US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/24]
TitleGerman:GEZIELTE ÖSOPHAGEALE VERABREICHUNG VON ZN-ALPHA2-GLYCOPROTEINEN (ZAG), VERFAHREN UND FORMULIERUNGEN DARAUS[2015/24]
English:TARGETED OESOPHAGEAL ADMINISTRATION OF ZN-ALPHA2-GLYCOPROTEINS (ZAG), METHODS AND FORMULATIONS THEREOF[2015/24]
French:ADMINISTRATION OESOPHAGIENNE CIBLÉE DE ZN-ALPA2-GLYCOPROTÉINES (ZAG), PROCÉDÉS ET FORMULATIONS ASSOCIÉS[2015/24]
Entry into regional phase27.02.2015National basic fee paid 
27.02.2015Designation fee(s) paid 
27.02.2015Examination fee paid 
Examination procedure27.02.2015Examination requested  [2015/24]
23.11.2015Amendment by applicant (claims and/or description)
21.11.2016Despatch of a communication from the examining division (Time limit: M06)
08.09.2017Reply to a communication from the examining division
03.08.2018Despatch of a communication from the examining division (Time limit: M06)
14.02.2019Application deemed to be withdrawn, date of legal effect  [2019/29]
14.03.2019Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2019/29]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  21.11.2016
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
08.09.2017Request for further processing filed
08.09.2017Full payment received (date of receipt of payment)
Request granted
20.09.2017Decision despatched
Fees paidRenewal fee
27.07.2015Renewal fee patent year 03
17.06.2016Renewal fee patent year 04
28.08.2017Renewal fee patent year 05
27.07.2018Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.07.201705   M06   Fee paid on   28.08.2017
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO2011161427  (UNIV ASTON [GB], et al) [X] 1-110 * examples 10,12; claim - *;
 [A]  - RUSSELL STEVEN THOMAS ET AL, "Role of beta-adrenergic receptors in the anti-obesity and anti-diabetic effects of zinc-alpha 2-glycoprotien (ZAG)", BIOCHIMICA ET BIOPHYSICA ACTA, (201204), vol. 1821, no. 4, pages 590 - 599, XP002712623 [A] 1-110 * abstract *

DOI:   http://dx.doi.org/10.1016/j.bbalip.2011.12.003
 [A]  - DE BOER ROBERT E P ET AL, "The beta-adrenoceptors mediating relation of rat oesophageal muscularis mucosae are predominantly of the beta-3-, but also of the beta-2-subtype", BRITISH JOURNAL OF PHARMACOLOGY, (1993), vol. 110, no. 1, ISSN 0007-1188, pages 442 - 446, XP002712624 [A] 1-110 * abstract *

DOI:   http://dx.doi.org/10.1111/j.1476-5381.1993.tb13830.x
by applicantUS6890899
 US2006160723
 US7550429
 US2010173829
    - "National Task Force on the Prevention and Treatment of Obesity", ARCH. INTERN. MED., (2000), vol. 160, pages 898 - 904
    - KHAODHIAR, L. ET AL., CLIN. CORNERSTONE, (1999), vol. 2, pages 17 - 31
    - T. ARAKI ET AL., "Complete amino acid sequence of human plasma Zinc-a2-glycoprotein and its homology to histocompatibility antigens", PROC. NATL. ACAD. SCI. USA., (1988), vol. 85, doi:doi:10.1073/pnas.85.3.679, pages 679 - 683, XP001120556

DOI:   http://dx.doi.org/10.1073/pnas.85.3.679
    - H. UEYAMA ET AL., "Cloning and nucleotide sequence of a human Zinc-a2- glycoprotein cDNA and chromosomal assignment of its gene", BIOCHEM. BIOPHYS. RES. COMMUN., (1991), vol. 177, doi:doi:10.1016/0006-291X(91)91844-3, pages 696 - 703, XP024835722

DOI:   http://dx.doi.org/10.1016/0006-291X(91)91844-3
    - UEYAMA ET AL., "Molecular cloning and chromosomal assignment of the gene for human Zinc-a2- glycoprotein", BIOCHEMISTRY, (1993), vol. 32, pages 12968 - 12976
    - H. UEYAMA ET AL., J. BIOCHEM., (1994), vol. 116, pages 677 - 681
    - OHKUBO ET AL., "Purification and characterisation of human plasma Zn-a2-glycoprotein", PREP. BIOCHEM., (1988), vol. 18, pages 413 - 430
    - H. UEYAMA ET AL., "Structure and Expression of Rat and Mouse mRNAs for Zn-a2 -glycoprotein", J. BIOCHEM., (1994), vol. 116, pages 677 - 681, XP009104382
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.